Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_assertion type Assertion NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_head.
- NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_assertion description "[Nevertheless, IL-1beta, ICAM-1 and NF-kappaB may be associated with primary resistance to glucocorticoids in NP, whereas higher expression of GR-beta in poor responders only after glucocorticoid treatment may represent a secondary drug resistance mechanism in this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_provenance.
- NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_assertion evidence source_evidence_literature NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_provenance.
- NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_assertion SIO_000772 19068102 NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_provenance.
- NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_assertion wasDerivedFrom befree-2016 NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_provenance.
- NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_assertion wasGeneratedBy ECO_0000203 NP708189.RAC9HmF3J4EkkPLEhnVuJHmJoLmBbLcdd-q0ruCkBTt-M130_provenance.